Middle East Pharmaceutical Industries Co. (4016.SR)
SAR 132.2
(-0.15%)
SAR 132.2
(-0.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 44.67 Million SAR | -26.99% |
| 2022 | 61.18 Million SAR | -10.02% |
| 2021 | 67.99 Million SAR | 45.52% |
| 2020 | 46.72 Million SAR | 717.01% |
| 2019 | -7.57 Million SAR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 14.32 Million SAR | -67.94% |
| 2024 Q2 | -15.29 Million SAR | -206.77% |
| 2023 Q4 | 44.67 Million SAR | 0.0% |
| 2023 Q1 | 23.79 Million SAR | -61.12% |
| 2023 Q3 | 44.67 Million SAR | -29.37% |
| 2023 Q2 | 63.24 Million SAR | 165.84% |
| 2023 FY | 44.67 Million SAR | -26.99% |
| 2022 Q3 | 61.18 Million SAR | 0.0% |
| 2022 FY | 61.18 Million SAR | -10.02% |
| 2022 Q4 | 61.18 Million SAR | 0.0% |
| 2022 Q1 | 19.03 Million SAR | 0.0% |
| 2021 FY | 67.99 Million SAR | 45.52% |
| 2020 FY | 46.72 Million SAR | 717.01% |
| 2019 FY | -7.57 Million SAR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Al-Dawaa Medical Services Company | 2.23 Billion SAR | 98.006% |
| Nahdi Medical Company | 265.09 Million SAR | 83.148% |
| Al-Razi Medical Co. | 11.02 Million SAR | -305.3% |
| Almujtama Alraida Medical Co. | 155.88 Million SAR | 71.343% |